A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study to find out whether codrituzumab is a safe treatment that causes few or mild side effects in children and young adults who have solid tumors that express the protein GPC3. The researchers also want to study the way codrituzumab is absorbed, distributed, and cleared from the body.
Epistemonikos ID: f9c83895b763187ed8364d9d81c63b8518b3cf44
First added on: May 09, 2024